The Cancer News commentary
Kaposi sarcoma (KS) represents one of the starkest global disparities in cancer care. While largely controlled in high-income countries through antiretroviral therapy (ART), KS continues to drive significant mortality in sub-Saharan Africa due to limited access to treatment, infrastructure challenges, and delayed diagnosis.
A commentary examines the biology, clinical spectrum, treatment landscape, and, critically, the barriers that continue to prevent equitable care for patients with KS worldwide.
Read the full commentary here.
Source : The Cancer News
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.